[ Price : $8.95]
FDA says it does not have scientific evidence on which to base a recommendation to continue using or discontinue Zantac due to the...[ Price : $8.95]
Sanofi researchers analyze FDA use of patient experience data in 2018 new molecular entity approvals to establish a baseline for f...[ Price : $8.95]
FDA extends the review of a Flexion Therapeutics supplemental NDA for Zilretta (triamcinolone acetonide extended-release injectabl...[ Price : $8.95]
A new JAMA study finds minimal effects from FDAs recent policies to expand approvals for generic drugs at risk for price spikes an...[ Price : $8.95]
FDA denies a 2006 citizen petition from UCB that sought labeling on all anti-epileptic drugs warning about drug switching patients...[ Price : $8.95]
A New York Times article examines FDAs alleged foot-dragging over the last decade that allowed e-cigarette use to explode to the d...[ Price : $8.95]
FDA accepts for review an Ultragenyx Pharmaceutical NDA for UX007 (triheptanoin) for treating long-chain fatty acid oxidation diso...[ Price : $8.95]
FDA clears an OssDsign 510(k) to market its Cranial PSI Accessories, which are a set of 3D-printed, patient-specific accessory dev...